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Background: Organ shortage has resulted in greater emphasis on partial liver transplantation (PLT) as an
alternative to whole-organ liver transplantation.
Methods: This study was conducted to assess outcomes in PLT and to compare outcomes of deceased
donor split-liver transplantation (DD-SLT) and live donor liver transplantation (LDLT) in adults transplanted
in the USA using data reported to the United Network for Organ Sharing in the era of Model for End-stage
Liver Disease (MELD) scores.
Results: Between 2002 and 2009, 2272 PLTs were performed in the USA; these represented 5.3% of all
liver transplants carried out in the country and included 557 (24.5%) DD-SLT and 1715 LDLT (75.5%)
procedures. The most significant differences between the DD-SLT and LDLT groups related to mean
MELD scores, which were lower in LDLT recipients (14.5 vs. 20.9; P < 0.001), mean recipient age, which
was lower in the LDLT group (50.7 years vs. 52.8 years; P < 0.001), and mean donor age, which was lower
in the DD-SLT group (23.0 years vs. 37.3 years; P < 0.001). Allograft survival was comparable between the
two groups (P = 0.438), but patient survival after LDLT was better (P = 0.04). In Cox regression analysis,
LDLT was associated with better allograft (hazards ratio [HR] = 0.7, 95% confidence interval [CI] 0.630–
0.791; P < 0.0001) and patient (HR = 0.6, 95% CI 0.558–0.644; P < 0.0001) survival than DD-SLT.
Conclusions: Partial liver transplantation represents a potentially underutilized resource in the USA.
Despite the differences in donor and recipient characteristics, LDLT is associated with better allograft and
patient survival than DD-SLT. A different allocation system for DD-SLT allografts that takes into consid-
eration cold ischaemia time and recipient MELD score should be considered.
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Introduction
The widening gap between the growing number of liver transplant
(LT) candidates and the supply of organs has become a strong
driver for the development of partial liver transplantation (PLT).1
Partial LT has progressed through a developmental phase and
become an established life-saving procedure.2–5 Partial allografts
can be obtained from living donors or by splitting a deceased
donor liver. Live donor LT (LDLT) has become the primary trans-
plant option in many Asian countries and is increasingly per-
formed as an adjunct transplant option in countries with low rates
of donation. Deceased donor split-liver transplantation (DD-SLT)
is a surgical method that creates two allografts from a liver sourced
from one deceased donor. The most widely used splitting tech-
nique involves dividing the liver into a left lateral sectoral allograft
(segments II and III) for a paediatric patient and a right trisectoral
allograft (segments I and IV–VIII) for an adult patient.6–8
Although many studies have compared outcomes in LDLT or
This study was presented at the 11th Annual Meeting of the American
Hepato-Pancreato-Biliary Association, 10–13 March 2011, Miami, Florida.
DOI:10.1111/j.1477-2574.2011.00360.x HPB
HPB 2011, 13, 797–801 © 2011 International Hepato-Pancreato-Biliary Association
DD-SLT with those in whole-organ LT, very few have compared
outcomes in LDLT and DD-SLT. The aim of this study was to
assess outcomes in PLT and to compare DD-SLT and LDLT in
adults based on data reported to the United Network for Organ
Sharing (UNOS) in the era of Model for End-stage Liver Disease
(MELD) scores.
Materials and methods
Adult liver transplants reported to the UNOS Organ Procurement
and Transplantation Network (OPTN) between February 2002
and December 2009 were investigated. Instances in which two
recipients received transplants sourced from one deceased donor
were considered as instances of DD-SLT. Paediatric cases of
DD-SLT and LDLT were excluded. Patient and donor characteris-
tics were evaluated. Outcomes such as length of stay, and allograft
and patient survival were analysed. Data on specific complications
were not available in the database. In addition, data on donors,
particularly live donors, were limited.
Chi-squared and Student’s t-tests were used to compare pro-
portions and means, respectively. Primary outcome measures
were graft and patient survival. Kaplan–Meier analysis was used to
estimate graft survival. Continuous variables were categorized
using exploratory data analysis and assumptions of proportional
hazards were met by extended Cox regression models with time-
dependent covariates. Unadjusted comparison of survival was
performed using the log-rank test. Hazard ratios (HRs) were esti-
mated using Cox proportional-hazards methodology and esti-
mates are reported as HR (95% confidence interval [CI]).
Multivariate Cox modelling was performed using potential risk
factors and covariates that were found to be statistically significant
in unadjusted Cox models. Statistical significance was defined as
P < 0.05.
This study was reviewed by the University of Massachusetts
Medical School Institutional Review Board (IRB) and deemed
appropriate for exemption from IRB oversight as the datasets
included no personal identifiers.
Results
Between 2002 and 2009, 2272 PLT procedures were performed in
the USA, representing 5.3% of all liver transplants carried out in
the country. These included 557 DD-SLTs (24.5%) and 1715
LDLTs (75.5%). In DD-SLTs, transplants were performed using a
right/right trisector (82.1%) or left lobe allograft (17.9%). In
LDLT procedures, transplants used the right/right trisector
(95.9%) and left hemiliver (4.1%).
Patient and donor demographics are shown in Table 1. Recipi-
ents of DD-SLTs were older and more likely to be female, but most
of the donors in both groups were male. Deceased donors were
significantly younger than live donors. Recipients of DD-SLTs had
significantly higher MELD scores and longer cold ischaemia time
(CIT) compared with LDLT recipients. The DD-SLT group
included more recipients with variceal bleeding and hepatic
encephalopathy, as well as greater use of dialysis before transplan-
tation, compared with the LDLT group. White patients predomi-
nated in the LDLT group to a greater extent than in the DD-SLT
group. Length of stay was comparable in the two groups.
Allograft survival (Fig. 1) was comparable between the two
groups (P = 0.438), but LDLT patients showed a trend for
improved patient survival (P = 0.04). In Cox regression analysis
(Table 2), LDLT was associated with better allograft (HR = 0.7,
95% CI 0.630–0.791; P < 0.0001) and patient (HR = 0.6, 95% CI
0.558–0.644; P < 0.0001) survival than DD-SLT (Table 3).
In the DD-SLT group, 223 (40.0%) procedures involved in situ
and 110 (19.7%) involved ex situ splitting. The method of splitting
the allograft was unknown in 224 (40.2%) procedures. There was
no difference in allograft survival based on the type of splitting
(Fig. 2).
Despite differences in donor and recipient characteristics, LDLT
was associated with better allograft and patient survival than
DD-SLT.
Discussion
In the last two decades, liver transplantation (LT) has become the
treatment of choice for patients with end-stage liver disease and
selected cases of hepatocellular carcinoma. Improvements in sur-
gical and anaesthesiological procedures have increased patient
survival after LT, resulting in excellent 1-year survival rates.
However, further increasing the number of LTs is rate-limited by
the extreme shortage of suitable organs and, in consequence,
patients die while on the waiting list. At present, patients on the
waiting list have reported mortality rates of 10–20%.1
As the liver possesses the unique ability to regenerate within a
short period, LDLT and DD-SLT represent opportunities to
combat the severe lack of deceased donor allografts by expanding
the donor pool. Reduced-size LT was first described by Bismuth
and Houssin in 1984.2 This innovative technique involved divid-
ing a whole liver into two parts, each of which included a vascular
pedicle, venous outflow and a bile duct. Broelsch et al.3 reported
an initial series of 26 DD-SLT procedures in 21 children and five
adults. These early cases used the ex vivo technique and results
were poor: only 67% of children and 20% of adults survived,
complication rates were high and the retransplant rate was 35%.
In the mid-1990s, several centres achieved results after DD-SLT
comparable with those after full-size LT.4–11 Graft and patient sur-
vival rates became equivalent to those found after full-size LT.
Deceased donor SLT has been shown to be an effective method
of expanding the organ pool for adults and children, although the
application of SLT has been limited in the USA.9,10 Although excel-
lent single-centre and statewide data exist, American Society of
Transplant Surgeons (ASTS) survey data and Scientific Registry of
Transplant Recipients (SRTR) data demonstrated inferior out-
comes of DD-SLT applied to adults in urgent need of LT.9,10 The
SRTR survey suggested that the performance of DD-SLT, presum-
ably using ‘optimal’ donors, delivered right graft outcomes
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comparable with those of ‘marginal grafts’. Although the number
of DD-SLTs carried out in the USA increased from 1996, the rate
of DD-SLT has remained relatively unchanged in recent years.
Currently, only 1.3% of deceased donor LTs performed in the USA
involve split livers.9 Donor age and condition are the most impor-
tant criteria for selecting livers for splitting. Ideal donor age
thresholds for splitting are not well defined, but many authors
have suggested that livers from donors aged >40–50 years or <10
years should not be considered.10 In this study, the mean donor
age in the DD-SLT group was only 23 years.
Since the first successful living-related donor LT, carried out
by Strong et al. in 1989,12 living-related donor LT has emerged as
an important option for many patients, particularly small pae-
diatric patients and adults who are disadvantaged within the
current deceased donor allocation system.10 Living donor LT can
now be performed with a reasonably high rate of success attrib-
utable to judicious patient selection, careful preoperative evalu-
ation, excellent anaesthetic management, surgeon experience,
and the prompt detection and treatment of complications.13–18
Both LDLT and DD-SLT aim to increase the availability of
grafts and to lower the death rate of patients on the waiting list,
and the similarity between the two procedures is significant in
terms of the technical aspects of donor and recipient surgery and
donor selection. However, differences between the two types of
transplantation in graft and recipient outcomes remain relatively
unknown. To our knowledge, the present study material repre-
sents the largest series of patients in which outcomes of DD-SLT
and LDLT have been compared.
This review identified significant differences in donor and
recipient characteristics between the DD-SLT and LDLT groups.
Table 1 Patient characteristics
Variables DD-SLT group LDLT group P-value
Recipient age, years, mean  SD 52.8  10 50.7  11 <0.001
Sex <0.001
Male 44.5% 54.6%
Female 55.5% 45.3%
Donor age, years, mean  SD 23.0  9.4 37.3  10 <0.001
Donor sex <0.001
Male 69.2% 50.7%
Female 30.9% 49.3%
Diagnosisa NS
Cholestatic 18.5% 18.1%
Hepatitis C 47.9% 47.4%
HCC 15.1% 15.8%
Alcohol 13.5% 14.9%
Cryptogenic 12.1% 12.5%
Other 3.4% 1.9%
MELD score, mean  SD 20.9  9.2 14.5  5.6 <0.001
CIT, h, mean  SD 8.2  3.7 3.1  5.9 <0.001
LoS, days, mean  SD 17.0  19.0 16.5  18.2 NS
Race <0.0001
White 64.2% 83.6%
African-American 11.8% 3.8%
Hispanic 20.8% 9.9%
Asian 1.9% 1.9%
Other 1.3% 0.8%
Hepatitis B core donors 0.4% 3.0% 0.0004
Variceal bleeding 7.9% 3.5% 0.0009
Ascites 79.1% 76.2% NS
Dialysis 8.4% 0.8% <0.0001
Encephalopathy 27.5% 19.3% 0.005
Some patients had more than one diagnosis
DD-SLT, deceased donor split-liver transplantation; LDLT, living donor liver transplantation; SD, standard deviation; NS, not significant; HCC,
hepatocellular carcinoma; MELD, Model for End-stage Liver Disease; CIT, cold ischaemia time; LoS, length of stay
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Donors of the DD-SLT material were younger and CIT at trans-
plant was longer in DD-SLT procedures. Recipients of DD-SLTs
were older and sicker, as evidenced by higher MELD scores, past
history of variceal bleeding and associated hepatic encephalopa-
thy, and as a result of being on dialysis before transplantation,
showing a patient group profile very similar to that of recipients of
whole-organ LTs. This study showed that LDLT is associated with
better allograft and patient survival than DD-SLT. These findings
may be explained by the elective nature of the LDLT procedure,
the better health of LDLT recipients and the shorter CIT in LDLT.
Deceased donor SLT is advantageous because it provides a larger
liver volume to the recipient, which includes a single bile duct in
most instances and a relatively longer and sometimes complete
hepatic artery. Conversely, the graft is recovered under suboptimal
conditions, on a non-elective basis, by teams with widely variable
degrees of expertise. Although the deceased donor is younger, the
impact of brain death and donor condition at the time of splitting
the graft cannot be underestimated. Both donor and recipient
factors may have contributed to the lower rates of patient and
graft survival in the DD-SLT group.
In the face of the severe organ shortage and high waiting list
mortality in the adult population, every effort should be made to
improve the utilization and outcomes of DD-SLT. If the proce-
dure is managed correctly, the advantages conferred by a
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Figure 1 (A) Allograft (P < 0.438) and (B) patient (P < 0.04) survival in the deceased donor split-liver transplantation (blue) and living donor
liver transplantation (red) groups
Table 2 Cox proportional hazard model predicting allograft survival
Variables HR (95% CI) P-value
Recipient age 1.01 (1.01–1.03) <0.001
Sex (male) 1.09 (1.04–1.14) 0.002
Race (White) 0.96 (0.45–0.099) 0.007
MELD score 1.03 (0.97–1.09) 0.3
Dialysis 1.41 (1.30–1.52) <0.0001
LDLT 0.70 (0.63–0.79) <0.001
HR, hazard ratio; 95% CI, 95% confidence interval; MELD, Model for
End-stage Liver Disease; LDLT, living donor liver transplantation
Table 3 Cox proportional hazard model predicting patient survival
Variables HR (95% CI) P-value
Age 1.01 (1.01–1.02) <0.001
Sex (male) 1.09 (1.03–1.15) 0.001
Race (White) 1.37 (1.26–1.48) <0.001
MELD score 0.96 (0.75–1.23) 0.75
Dialysis 1.52 (1.40–1.65) <0.001
LDLT 0.64 (0.55–0.74) <0.001
HR, hazard ratio; 95% CI, 95% confidence interval; MELD, Model for
End-stage Liver Disease; LDLT, living donor liver transplantation
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younger donor population, larger liver grafts, the presence of a
single bile duct and a longer hepatic artery should translate into
better graft and patient survival rates. The negative impacts of
both higher recipient MELD scores and lengthy CIT observed
in deceased donor whole-liver transplants are most probably
amplified in the DD-SLT group and should be taken into
consideration.
In conclusion, DD-SLT represents a potentially underutilized
resource in the USA. Factors such as high recipient MELD score
and lengthy CIT may have negative effects on results in DD-SLT
and therefore deter surgeons from performing this procedure. A
different allocation system for these grafts that takes into
consideration CIT and recipient MELD score should be
considered.
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Figure 2 Allograft survival in deceased donor split-liver transplantation according to splitting technique (P < 0.35). Blue, in situ splitting; red,
ex situ splitting; green, unknown splitting
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